Home > Boards > US Listed > Biotechs >

Genocea Biosciences, Inc (GNCA)

GNCA RSS Feed
Add GNCA Price Alert      Hide Sticky   Hide Intro
Moderator: NY1972
Search This Board: 
Last Post: 5/16/2022 12:37:15 PM - Followers: 35 - Board type: Free - Posts Today: 1

GNCA
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GNCA News: Quarterly Report (10-q) 05/05/2022 12:16:23 PM
GNCA News: Genocea Biosciences (GNCA) Receives a Buy from Leerink Partners 05/02/2022 07:15:19 AM
GNCA News: Amended Annual Report (10-k/a) 04/29/2022 12:32:28 PM
GNCA News: Why Did H.C. Wainwright Downgrade Genocea Biosciences’ Stock? 04/29/2022 02:16:03 AM
GNCA News: Current Report Filing (8-k) 04/28/2022 12:22:17 PM
PostSubject
#914   PR https://www.prnewswire.com/news-releases/pact-pharma-highlights-capabilities- jondoeuk 05/16/22 12:37:15 PM
#913   ''NT-125 is an investigational, autologous, fully-individualized, multi-specif jondoeuk 05/10/22 01:23:25 PM
#912   189: A Versatile, Non-Viral Gene Editing Method for jondoeuk 05/02/22 05:02:24 PM
#911   Hopefully, this will play out similar to MRK jondoeuk 04/29/22 08:15:50 PM
#910   Biotechs are filled with frauds. Investors kept in NY1972 04/28/22 07:08:11 PM
#909   CEO knew Planet failed when DP was made NY1972 04/28/22 06:58:10 PM
#908   NPT turned out to be a lost TIL. NY1972 04/28/22 06:10:02 PM
#907   Turnstone Bio https://www.businesswire.com/news/home/20220425005377/en/Turnstone jondoeuk 04/27/22 07:18:43 PM
#906   By Q4 (GEN-011) jondoeuk 04/27/22 07:14:47 PM
#905   From this: ''Using high-dimensional analysis of human ACT jondoeuk 04/27/22 04:38:25 PM
#904   young” tumor infiltrating lymphocytes can mediate regression of NY1972 04/27/22 01:20:02 PM
#903   Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors NY1972 04/26/22 08:59:31 PM
#902   Intratumoral CD40 agonist sotigalimab with pembrolizumab induces broad NY1972 04/25/22 09:19:16 PM
#901   Mellman described published work linking PD-1 and CD28 NY1972 04/25/22 09:10:38 PM
#900   Bio chop suey :-): Orca-T is an investigational NY1972 04/25/22 10:25:15 AM
#899   The poster jondoeuk 04/24/22 03:33:12 PM
#898   Speaking of GvHD, Orca Bio (an IPO could jondoeuk 04/24/22 02:01:57 PM
#897   Some slides from a presentation given at ESMO jondoeuk 04/24/22 01:55:48 PM
#896   High-Dose Cyclophosphamide Reduces Graft-Versus-Host Disease Following Stem Cell NY1972 04/23/22 10:47:47 PM
#895   Emergence of tumor mismatch repair deficiency and increased NY1972 04/23/22 10:21:40 PM
#894   The reason high-dose cyclophosphamide is able to ablate NY1972 04/23/22 10:05:37 PM
#893   NeoPhore is developing first-in-class small molecule inhibitors to jondoeuk 04/23/22 06:56:20 PM
#892   Fludarabine exposure predicts outcome after CD19 CAR T-cell NY1972 04/22/22 09:21:56 PM
#891   MC = 64 doses CAR T NY1972 04/22/22 09:53:38 AM
#890   T cells CPD NY1972 04/21/22 08:24:10 PM
#889   GNCA Buyers and sellers feel like TILS :-) NY1972 04/21/22 06:31:09 PM
#888   Last Smart Money left the bldg. only dummies NY1972 04/21/22 10:37:09 AM
#887   Analysis of severe lymphodepletion on the day of NY1972 04/20/22 08:35:52 PM
#886   Cyclophosphamide alters the tumor cell secretome to potentiate NY1972 04/20/22 04:15:38 PM
#885   Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant NY1972 04/20/22 04:05:04 PM
#884   The effect of low-dose IL-2 and Treg adoptive NY1972 04/19/22 11:32:52 PM
#883   A PhI trial (NCT04217473) is assessing an 'armed' jondoeuk 04/17/22 04:58:49 PM
#882   They use high-dose IL-2. jondoeuk 04/17/22 04:49:03 PM
#881   Did IOVA use intermediate dose IL-2 post NY1972 04/17/22 12:30:44 PM
#880   ACT?+?NKTR-214 achieves long-lasting anti-tumor responses NY1972 04/17/22 11:33:28 AM
#879   IO backbone not getting new support beam. IL-2 NY1972 04/15/22 11:15:03 AM
#878   Thx NY! Imokhopeur 04/13/22 09:07:44 PM
#877   Enjoy the very hot bath. No clothes or NY1972 04/13/22 04:38:59 PM
#876   I’m in! Imokhopeur 04/13/22 01:36:30 PM
#874   Time to load up oversold here $$$$ INFINITI 04/12/22 10:44:59 AM
#873   Leerink Partners Thinks Genocea Biosciences’ Stock is Going INFINITI 04/12/22 06:02:34 AM
#871  Restored Cmon slap that as$$k INFINITI 04/11/22 03:10:13 PM
#870   Oversold last week NY1972 04/11/22 12:22:23 PM
#869   Looks good I’m in price target $9 wow INFINITI 04/11/22 11:55:39 AM
#868   Why is this running today? PennyPusher786 04/11/22 11:23:54 AM
#867   GNCA: $9.00 price target by Wainwright; ya might Just-Keep-Trying 04/11/22 10:35:56 AM
#865   GNCA: (NEWS) Today's PRICE analysis says GNCA going Just-Keep-Trying 04/11/22 10:09:37 AM
#860   HD lympho results in better chance to shift NY1972 04/11/22 09:21:59 AM
#859   +50% G2G 04/11/22 06:12:11 AM
#858   Based on the clinical data so far, patients jondoeuk 04/10/22 09:51:27 PM
PostSubject
Consent Preferences